---
title: Association of digital and manual quantification of tumor PD-L1 expression with outcomes in nivolumab-treated patients
description: Association of digital and manual quantification of tumor PD-L1 expression with outcomes in nivolumab-treated patients
---

[PathAI Resources ](https://www.pathai.com/resources)

# [Association of digital and manual quantification of tumor PD-L1 expression with outcomes in nivolumab-treated patients](https://www.pathai.com/resources/association-of-digital-and-manual-quantification-of-tumor-pd-l1-expression-with-outcomes-in-nivolumab-treated-patients)

 Written by [Admin](https://www.pathai.com/resources/author/admin) | Jun 22, 2020 4:00:00 AM

## Study Background

 Programmed death ligand 1 (PD-L1) is a biomarker associated with response to programmed death-1 (PD-1) and PD-L1 immune checkpoint inhibitors1\r\n\u2022 Four immunohistochemistry (IHC) assays for PD-L1 expression have been approved\r\nacross a number of tumor types\r\n\u2022 Manual assessment of PD-L1 expression is limited by variability in assay and scoring methodology, heterogeneous tumor PD-L1 expression, and interobserver variability\r\n\u2014 Interpathologist discordance may increase for tumor samples with low\r\nexpression of PD-L1\r\n\r\n\u2022 Digital quantification may improve the precision of PD-L1 assessment by\r\novercoming certain limitations observed with manual scoring, as suggested in various tumor types, including non-small cell lung cancer, melanoma (MEL), and urothelial carcinoma (UC)

[View Poster](https://www.pathai.com/hubfs/2025%20Assets/Copy-of-Duan_AACR20_Poster_Digital_vs_Manual_Pathology_Final_2017.pdf)

[View full post](https://www.pathai.com/resources/association-of-digital-and-manual-quantification-of-tumor-pd-l1-expression-with-outcomes-in-nivolumab-treated-patients)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Admin"
  },
  "dateModified" : "2025-07-30T05:31:43.399Z",
  "datePublished" : "2020-06-22T04:00:00Z",
  "headline" : "Association of digital and manual quantification of tumor PD-L1 expression with outcomes in nivolumab-treated patients",
  "image" : {
    "@type" : "ImageObject",
    "height" : 60,
    "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
    "width" : 60
  },
  "mainEntityOfPage" : "https://www.pathai.com/resources/association-of-digital-and-manual-quantification-of-tumor-pd-l1-expression-with-outcomes-in-nivolumab-treated-patients",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "PathAI Resources"
  }
}
```